Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 23, 2016
Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice
Marta Zielińska, Agata Jarmuż, Maciej Sałaga, et al.
Neuro Endocrinology Letters
|
August 27, 2002
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system
Paolo Lissoni, Fabio Malugani, Ola Malysheva, et al.
Hormones and Behavior
|
May 9, 2013
A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease
Pingping He, Xinping Ouyang, Shouhong Zhou, et al.
Journal of Alzheimer'S Disease : JAD
|
May 28, 2017
CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology
Elhanan Pinner, Yaron Gruper, Micha Ben Zimra, et al.
BMC Medicine
|
August 18, 2010
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
Alan G Wade, Ian Ford, Gordon Crawford, et al.
Current Medical Research and Opinion
|
November 25, 2010
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response
Alan G Wade, Gordon Crawford, Ian Ford, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2017
Melatonin Receptor Agonist Piromelatine Ameliorates Impaired Glucose Metabolism in Chronically Stressed Rats Fed a High-Fat Diet
Jun Zhou, Deng Wang, XiaoHong Luo, et al.
European Journal of Pharmacology
|
February 4, 2014
Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats
Meihua She, Xiaobo Hu, Zehong Su, et al.
European Journal of Pharmacology
|
July 9, 2017
Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats
Jun Zhou, Jin Zhang, XiaoHong Luo, et al.
Acta Biochimica Et Biophysica Sinica
|
March 31, 2016
Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance
Xiuping Li, Shichang Cai, Weidong Yin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 23, 2016
Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice
Marta Zielińska, Agata Jarmuż, Maciej Sałaga, et al.
Neuro Endocrinology Letters
|
August 27, 2002
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system
Paolo Lissoni, Fabio Malugani, Ola Malysheva, et al.
Hormones and Behavior
|
May 9, 2013
A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease
Pingping He, Xinping Ouyang, Shouhong Zhou, et al.
Journal of Alzheimer'S Disease : JAD
|
May 28, 2017
CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology
Elhanan Pinner, Yaron Gruper, Micha Ben Zimra, et al.
BMC Medicine
|
August 18, 2010
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
Alan G Wade, Ian Ford, Gordon Crawford, et al.
Current Medical Research and Opinion
|
November 25, 2010
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response
Alan G Wade, Gordon Crawford, Ian Ford, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2017
Melatonin Receptor Agonist Piromelatine Ameliorates Impaired Glucose Metabolism in Chronically Stressed Rats Fed a High-Fat Diet
Jun Zhou, Deng Wang, XiaoHong Luo, et al.
European Journal of Pharmacology
|
February 4, 2014
Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats
Meihua She, Xiaobo Hu, Zehong Su, et al.
European Journal of Pharmacology
|
July 9, 2017
Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats
Jun Zhou, Jin Zhang, XiaoHong Luo, et al.
Acta Biochimica Et Biophysica Sinica
|
March 31, 2016
Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance
Xiuping Li, Shichang Cai, Weidong Yin, et al.
Page
of 4